Document is current
Any future updates will be listed below
-
Authors
Bruxel, E. M.
Moreira-Maia, C. R.
Akutagava-Martins, G. C.
Quinn, T. P.
Klein, M. https://orcid.org/0000-0001-8784-5679
Franke, B. https://orcid.org/0000-0003-4375-6572
Ribasés, M.
Rovira, P.
Sánchez-Mora, C. https://orcid.org/0000-0003-4211-1107
Kappel, D. B.
Mota, N. R. https://orcid.org/0000-0003-3504-759X
Grevet, E. H.
Bau, C. H. D.
Arcos-Burgos, M.
Rohde, L. A.
Hutz, M. H.
- License Information
-
More Information
Article History
Received: 12 November 2018
Revised: 13 January 2020
Accepted: 30 January 2020
First Online: 12 February 2020
Compliance with ethical standards
:
: CRMM receives financial research support from the government agency: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). CRMM received fees for the development of educational materials for Libbs, Novartis, and Pfizer. He has served as a consultant and served on the speakers’ bureau of Shire. Libbs, Novartis, and Shire make products for the treatment of ADHD. CRMM received travel, accommodation, and registration support to the fourth and fifth World Congress on ADHD from the World Federation of ADHD. EHG was on the speaker’s bureau for Novartis and Shire, and Shire’s national and international advisory boards for the last 3 years. He also received travel awards (air tickets and hotel accommodations) for participating in two psychiatric meetings from Shire and Novartis. LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Eli Lilly and Co., Janssen, Medice, Novartis and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by LAR have received unrestricted educational and research support from the following pharmaceutical companies: Eli Lilly and Co., Janssen, Novartis, and Shire. LAR has received authorship royalties from Oxford Press and ArtMed and travel grants from Shire to take part in the 2018 APA and from Novartis to take part of the 2015 WFADHD congresses. MHH receives financial research support from the Brazilian governmental agency: CNPq. EMB and GCAM have received financial research support from CNPq. CHDB and DBK have received financial support from the following Brazilian agencies: CNPq, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and HCPA (FIPE-HCPA). BF has received educational speaking fees from Shire and Medice. She also is supported by the personal Vici grant from the Netherlands Organisation for Scientific Research (NWO). PR is a recipient of a predoctoral fellowship from the Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya, Spain (2016FI_B 00899). TPQ, MK, MR, NRM, and MAB have no competing interests.
